61636-30-4

Basic information

• Product Name: Morpholine, 2,6-dimethyl-4-(phenylmethyl)-
• Synonyms: 4-benzyl-2,6-dimethyl-morpholine;4-Benzyl-2,6-dimethylmorpholin;4-benzyl-dimethyl-morpholine
• CAS NO: 61636-30-4
• Molecular Formula: C13H19NO
• Molecular Weight: 205.3
• Mol File: 61636-30-4.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 102-104 °C(Press: 3 Torr)
• Density: 0.992±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Morpholine, 2,6-dimethyl-4-(phenylmethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Morpholine, 2,6-dimethyl-4-(phenylmethyl)-(61636-30-4)
• EPA Substance Registry System: Morpholine, 2,6-dimethyl-4-(phenylmethyl)-(61636-30-4)

Safety Data

• Hazardous Substances Data: 61636-30-4(Hazardous Substances Data)

Upstream product

• 141-91-3 2,6-dimethyl morpholine 
• 100-46-9 benzylamine 
• 100-39-0 benzyl bromide 
• 100-44-7 benzyl chloride 

Downstream Products

• 80567-00-6 2,6-dimethylmorpholine hydrochloride 

Relevant articles and documents

Method of producing higher amine (by machine translation)

PROBLEM TO BE SOLVED: To provide a method of producing a secondary or tertiary higher amine. SOLUTION: The method of producing a higher amine comprises allowing a primary or secondary amine to react with an alcohol in the presence of at least one species of hydrogen halide selected from hydrogen chloride, hydrogen bromide and hydrogen iodide, or in the presence of a compound capable of producing a hydrogen halide (such as 1,3,5-triazo-2,4,6-triphosphorine-2,2,4,4,6,6-chloride). If the raw material amine is a primary amine, a secondary higher amine and a tertiary higher amine can be produced. If the raw material amine is a secondary amine, a tertiary higher amine can be produced. COPYRIGHT: (C)2012,JPO&INPIT

8-PYRAZINYL-S-SPIROPYRIMIDINETRIONE-OXAZINOQUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS

Described herein are antibacterial compounds, methods for making the compounds, pharmaceutical compositions containing the compounds and methods of treating bacterial infections utilizing the compounds and pharmaceutical composition.